New perhydro-1,4-oxazine derivatives of arylethanolamine with beta 3-adrenoceptor agonist activity.
Monge
A
A
Department of Medicinal Chemistry, University of Navarra, Pamplona, Spain.
Aldana
I
I
Cerecetto
H
H
Rivero
A
A
Del Barrio
A
A
Perez
R
R
Portillo
M
M
Martinez
A
A
D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects; D000318:Adrenergic beta-Agonists / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D066298:In Vitro Techniques; D010078:Oxazines / Q000138:chemical synthesis* / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010642:Phenoxyacetates / Q000494:pharmacology; D051381:Rats; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D022702:Receptors, Adrenergic, beta-3
D000318:Adrenergic beta-Agonists; D010078:Oxazines; D010627:Phenethylamines; D010642:Phenoxyacetates; D011943:Receptors, Adrenergic, beta; D022702:Receptors, Adrenergic, beta-3; C074655:ICI 198157; C063157:BRL 35135